In this ASCO Journal of Clinical Oncology special series on clinical trial eligibility, you can learn more about why more patients will be eligible for clinical trials. It’s also important to know if outcomes and side effects differ based on a participant’s sex, race or age group. The FDA’s Drug Trials Snapshots allows you to see who took part in the clinical trials that led to a drug’s approval and what, if any, differences were seen. And Cancer Today, pulls it all together in this feature on efforts to increase the number and type of participants in clinical trials.
Last Modified on February 10, 2021